Business Award Recognises Outstanding Achievement
German laboratory instrument manufacturer Knauer Wissenschaftliche Geräte GmbH, has been honoured to receive the VORSPRUNG Business Award for the Berlin region during a ceremony at the city’s Federal Chancellery on May 9.
Patron Carsten Schneider, Minister of State and Federal Government Commissioner for Eastern Germany presented the Award, an accolade of the East German Business Forum OWF, to entrepreneur and Managing Director Alexandra Knauer and Managing Director Carsten Losch.
“We are very pleased to receive this recognition and are honoured to be seen as a role model and a contributor to the transformation of the economy. At Knauer, we are committed to pursuing new opportunities and operating sustainably. It is great that we have been able to network with the outstanding companies also honoured today,” Mr Losch said at the ceremony.
The Award winners, selected for their high level of innovation, healthy growth and as being exemplary for the sustainable transformation of the economy, were chosen by an independent jury of experts headed by Matthias Platzeck, former Minister President of the state of Brandenburg.
The East German Business Forum (OWF), is a project of the initiative Germany - Land of Ideas. It offers an important platform for all topics relating to the region as a business sector, aiming to highlight the opportunities and challenges that exist to connect players from business, politics and science, as well as develop approaches to solutions for the structural change and transformation processes that are shaping the future landscape.
Based in Berlin-Zehlendorf, Knauer has a 60-year tradition in building scientifi c instrumentation for the life science, pharmaceutical, biotechnology, chemical, environmental and food industries. As a leading German supplier of liquid chromatography solutions the company proved agile and adept in development of a novel mixing process for mRNA vaccines at record speed, assisting in the production of billions of Corona vaccine doses.
Knauer management with ‘Land of Ideas’ Managing Director Dr Phillipp Mehne (left) and Minister of State Carsten Schneider (right) (Credit : Germany – Land of Ideas/Bernd Brundert)
Company owner Alexandra Knauer manages the family business together with Carsten Losch. Both are committed to sustainable and responsible corporate governance with a focus on the users, the 190 employees and society.
More information online:
ilmt.co/PL/8jZo 60391pr@reply-direct.com
Business Divisions Refl ect Positive Performance
Fiscal year 2022 saw global Life Sciences group Eppendorf’s consolidated revenue increase by €1.23 billion from €1.1 billion a year ago – an increase of 12.1% compared to 13.8% in 2021. Operating profi t amounted to €225.6 million against €272 million 12 months earlier. The EBIT margin was 8.3% compared to 24.7%.
Co-CEOs of Eppendorf SE, Eva van Pelt and Dr Peter Fruhstorfer summarised the year as ‘very challenging yet successful’ against factors such as Russia’s attack on Ukraine, the energy crisis, supply chain disruption and rising infl ation rates in numerous countries. “These challenges were handled in an outstanding manner by the Group’s more than 5,000 employees worldwide. They played a major part in making this success possible,” added Ms van Pelt, a sentiment echoed by Dr Fruhstorfer.
The Bioprocess business unit generated sales of more than €100 million, with the Separation and Instrumentation division sales up 14.1%, while Liquid Handling grew by 14.0%. Sales in China grew by 27.6% despite restrictions imposed by corona lockdowns in cities such as Shanghai. The Americas and Asia/Pacifi c/Africa (APA) regions achieved sales growth of 26.1% and 10.4% respectively. In Europe, hard hit by the Ukraine war, sales declined by 5.7%; this was primarily attributed to a normalisation of customer demand, not unexpected after the Corona-related strong sales years of 2020 and 2021.
“In the past year, we continuously invested in the expansion of our international infrastructure. The focus was on new sales and service locations worldwide,
new logistics sites, for example in Singapore and Enfi eld, USA, as well as the further expansion of our production capacities,” said Ms van Pelt.
“With the acquisition of a production site in Wismar, Eppendorf has once again demonstrated its commitment to Germany as a production location. By building a high-tech plant for laboratory consumables, Eppendorf is strengthening one of its core businesses and stabilising strained supply chains through local value creation,” explained Dr Fruhstorfer.
A new production site for centrifuges in Shanghai, China, helped to minimise logistics and transport costs, while supporting the company’s target to be climate-neutral by 2028.
Investment of 17.8% to €76 million by Eppendorf into its R&D budget, brought a strong focus on product development and digitalisation; its new sustainable tubes/consumables, made from material derived from organic food industry residues, was noted as a visible success.
Overall Eppendorf remains optimistic for the full year 2023, anticipating a weaker, but overall stable development of demand and expectations of sales growth in the single-digit percentage range.
More information online:
ilmt.co/PL/Z4LO 60392pr@reply-direct.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176 |
Page 177 |
Page 178 |
Page 179 |
Page 180 |
Page 181 |
Page 182 |
Page 183 |
Page 184 |
Page 185 |
Page 186 |
Page 187 |
Page 188
